Ticker Details
Aquestive Therapeutics, Inc.
IPO Date:	July 23, 2018
Sector:	Healthcare
Industry:	Drug Manufacturers - Specialty and Generic
Market Cap:	$516.85M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.16 | 3.68%
Avg Daily Range (30 D):	$0.08 | 1.77%
Avg Daily Range (90 D):	$0.09 | 2.36%

Institutional Daily Volume
Avg Daily Volume:	.97M
Avg Daily Volume (30 D):	1.41M
Avg Daily Volume (90 D):	2.8M

Trade Size
Avg Trade Size (Sh.):	178
Avg Trade Size (Sh.) (30 D):	136
Avg Trade Size (Sh.) (90 D):	165

Institutional Trades
Total Institutional Trades:	299
Avg Institutional Trade:	$1.56M
Avg Institutional Trade (30 D):	$1.4M
Avg Institutional Trade (90 D):	$1.13M
Avg Institutional Trade Volume:	.36M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.56M
Avg Closing Trade (30 D):	$1.38M
Avg Closing Trade (90 D):	$1.05M
Avg Closing Volume:	333.68K

News

May 2, 2026 @ 8:00 PM AQST DEADLINE: ROSEN, NATIONAL TRIAL LAWYERS, Enco... Source: Rosen Law Firm

Apr 30, 2026 @ 4:00 PM Bronstein, Gewirtz & Grossman LLC Urges Atara Biot... Source: Bronstein, Gewirtz & Grossman Llc

Apr 30, 2026 @ 12:04 AM Bragar Eagel & Squire, P.C. Reminds Aquestive Ther... Source: Bragar Eagel & Squire, P.C.

Apr 28, 2026 @ 1:00 PM Portnoy Law Firm Announces Class Action on Behalf ... Source: Portnoy Law Firm

Apr 27, 2026 @ 4:00 PM Bronstein, Gewirtz & Grossman LLC Urges Aquestive ... Source: Bronstein, Gewirtz & Grossman Llc

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.07	$-.27	$-.78
Diluted EPS	$-.07	$-.27	$-.78
Revenue	$14.45M	$13.02M	$44.55M
Gross Profit	$10.98M	$7.18M	$25.99M
Net Income / Loss	$-8.06M	$-31.86M	$-83.78M
Operating Income / Loss	$-4.2M	$-28.84M	$-71.05M
Cost of Revenue	$3.47M	$5.84M	$18.56M
Net Cash Flow	$-10.44M	$-7.89M	$49.62M
PE Ratio